---
figid: PMC9027317__marinedrugs-20-00225-g003a
pmcid: PMC9027317
image_filename: marinedrugs-20-00225-g003a.jpg
figure_link: .na.character
number: ''
figure_title: Figure 3
caption: 'Oil Red O staining of FFA-treated liver cells (×400, scale bars of images
  are 20 μm) (A) and oil droplets analyzed by Image J (B). Data are expressed as mean
  ± standard deviation (n = 5), ** p < 0.01 vs. control group, # p < 0.05, ## p <
  0.01 vs. FFA group.'
article_title: Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver
  Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4
  Signaling Pathway.
citation: Jiena Ye, et al. Mar Drugs. 2022 Apr;20(4):225.
year: '2022'

doi: 10.3390/md20040225
journal_title: Marine Drugs
journal_nlm_ta: Mar Drugs
publisher_name: MDPI

keywords:
- NAFLD
- fucoxanthin
- adenosine monophosphate-activated protein kinase (AMPK)
- nuclear factor erythroid-2-related factor 2-mediated (Nrf2)
- Toll-like receptor 4-mediated (TLR4)

---
